Skip to main content
. 2021 Oct 19;9(11):e1610–e1617. doi: 10.1016/S2214-109X(21)00338-7

Table 2.

MNTE performance indicators in the 12 countries that have not achieved MNTE

TTCV2+ coverage from the WHO/UNICEF Joint Reporting Form6
MNTE indicators from most recent DHS7or MICS8
TTCV2+ coverage in 2019 TTCV2+ coverage during the year of most recent DHS or MICS Year of most recent DHS or MICS TTCV2+ PAB Health facility delivery SBA ANC1
Afghanistan 85% 93% 2015 34% 53% 48% 51% 59%
Angola 54% 70% 2016 56% 66% 46% 50% 82%
Central African Republic 86% 76% 2010 ND ND 53% ND 68%
Guinea 94% 91% 2018 48% 59% 53% 55% 81%
Mali 72% 75% 2018 36% 50% 67% 67% 80%
Nigeria 40% 50% 2018 53% 62% 39% 43% 67%
Pakistan 62% 60% 2018 57% 64% 62% 64% 80%
Papua New Guinea 31% 25% 2018 27% 38% 55% 55% 76%
Somalia 58% 58% 2020 17% 27% 21% 32% 31%
South Sudan 38% 46% 2010 28% 37% 12% 19% 62%
Sudan 53% 53% 2014 32% 58% 28% 78% 79%
Yemen 25% 18% 2013 9% 28% 30% 45% 60%

ANC1=first antenatal care visit. DHS=Demographic Health Survey. MICS=Multiple Indicator Cluster Survey. MNTE=maternal and neonatal tetanus elimination. ND=no data available. PAB=protection at birth. SBA=skilled birth attendance. TTCV2+=at least two doses of tetanus toxoid-containing vaccine.